1350 studies found for:    "Liver Neoplasms"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
Conditions: Liver Neoplasms;   Hepatic Cancer;   Liver Cancer
Interventions: Procedure: Thermal Ablation;   Procedure: Standard External Beam Radiation Therapy
2 Recruiting Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Adult Primary Undifferentiated Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Childhood Hepatocellular Carcinoma;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Childhood Liver Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC);   Stage III Childhood Liver Cancer;   Stage IV Childhood Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
3 Recruiting PET/CT-Assessment of Liver Tumor Ablation
Conditions: Liver Tumor;   Liver Neoplasms
Interventions: Radiation: N-13 ammonia;   Device: PET/CT scanner
4 Recruiting 3-Tesla MRI Response to TACE in HCC (Liver Cancer)
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Stage A Adult Primary Liver Cancer (BCLC);   Stage B Adult Primary Liver Cancer (BCLC)
Interventions: Device: 3 Tesla Magnetic Resonance Imaging;   Drug: Magnevist® (Intravenous (IV) administration of MRI contrast agent)
5 Completed Oxaliplatin in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: oxaliplatin;   Other: laboratory biomarker analysis
6 Completed
Has Results
Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Biological: bevacizumab;   Drug: erlotinib hydrochloride
7 Active, not recruiting Biomarkers in Tissue Samples From Young Patients With Liver Cancer
Conditions: Childhood Hepatoblastoma;   Stage I Childhood Liver Cancer;   Stage II Childhood Liver Cancer;   Stage III Childhood Liver Cancer;   Stage IV Childhood Liver Cancer
Interventions: Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: nucleic acid sequencing;   Other: diagnostic laboratory biomarker analysis
8 Recruiting Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
Conditions: Childhood Hepatoblastoma;   Stage I Childhood Liver Cancer;   Stage II Childhood Liver Cancer;   Stage III Childhood Liver Cancer;   Stage IV Childhood Liver Cancer
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: fluorouracil;   Drug: vincristine sulfate;   Drug: doxorubicin hydrochloride;   Drug: irinotecan hydrochloride;   Procedure: liver transplantation;   Other: laboratory biomarker analysis
9 Active, not recruiting Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
10 Not yet recruiting TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Recurrent Adult Primary Liver Cancer;   Stage A Adult Primary Liver Cancer (BCLC);   Stage B Adult Primary Liver Cancer (BCLC);   Stage C Adult Primary Liver Cancer (BCLC)
Interventions: Procedure: transarterial chemoembolization;   Radiation: stereotactic radiosurgery
11 Active, not recruiting CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
Conditions: Advanced Hepatocellular Carcinoma;   Liver Cancer;   Hepatic Cancer;   Liver Neoplasms
Interventions: Drug: CS-1008;   Drug: sorafenib
12 Terminated IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
Conditions: Cancer of the Liver;   Liver Cancer;   Hepatoma;   Liver Neoplasms;   Biliary Cancer
Intervention: Biological: Salmonella typhimurium
13 Recruiting Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed By Surgery
Conditions: Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Childhood Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Recurrent Gallbladder Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC);   Stage II Gallbladder Cancer;   Stage III Childhood Liver Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Childhood Liver Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Interventions: Drug: trametinib;   Drug: leucovorin calcium;   Drug: fluorouracil;   Drug: capecitabine;   Other: laboratory biomarker analysis
14 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Intervention: Drug: OMP-54F28 with Sorafenib
15 Recruiting Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma;   Liver Neoplasms;   Adenoma, Liver Cell;   Carcinoma, Hepatocellular
Interventions: Drug: TRC 105;   Drug: Sorafenib
16 Recruiting TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   Liver Neoplasm;   Primary Liver Cancer
Intervention: Device: TheraSphere
17 Completed Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: bortezomib
18 Completed
Has Results
IMC-A12 in Treating Patients With Advanced Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Biological: cixutumumab;   Procedure: computed tomography;   Procedure: contrast-enhanced magnetic resonance imaging
19 Completed
Has Results
Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: selumetinib;   Other: pharmacological study
20 Active, not recruiting Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Biological: cixutumumab;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years